Welcome to the website for the RTI Surgalign Holdings, Inc. Fair Fund.
Important Update: Pursuant to paragraph 36 of the Distribution Plan, the Fund Administrator may extend any procedural deadline contained in the plan for good cause. The Fund Administrator, with agreement of Commission staff, has extended the Fair Fund claim filing date by 90 days, to February 23, 2026.
If you purchased and/or acquired RTI common stock during the period of time from April 23, 2015, through March 16, 2020, inclusive (“Relevant Period”) you may be entitled to a Distribution Payment from the RTI Surgalign Holdings, Inc. Fair Fund.
Background:
On August 3, 2022, the Commission issued the Order instituting and simultaneously settling administrative and cease-and-desist proceedings against the Respondents. In the Order, the Commission found that from 2015 through 2019, Surgalign Holdings, Inc. (formerly known as RTI Surgical Holdings, Inc. and RTI Surgical, Inc.) (“RTI”) shipped orders weeks or months before its customers had originally requested delivery, thereby pulling sales forward from future quarters, to address projected quarterly revenue shortfalls. In some instances, RTI did so after requesting and obtaining customer permission; in other instances, RTI shipped orders early without customer approval and then prematurely recognized revenue for the sales. In multiple quarters, RTI would not have met its revenue guidance without these undisclosed pull-forwards. RTI and its former senior management, including its CFO until September 2017, Robert Jordheim, did not disclose to investors that RTI’s apparent success at achieving its revenue guidance resulted from its reliance on pull-forwards, and they did not disclose the known uncertainty that this practice created for RTI’s future revenue streams. In 2020, RTI issued a restatement to correct, among other things, its premature recognition of revenue, in violation of generally accepted accounting principles (GAAP), for orders shipped early to customers without their approval.